Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
* Wspomniani autorzy wnieśli do projektu równy wkład.
Here, a protocol involving re-arterialized rat partial liver transplantation is presented. Specifically, 70% liver was resected in vivo by using an updated technique of vessel-oriented hepatectomy. The hepatic artery was reconstructed in an end-to-side manner. The cuff technique was modified to shorten the anastomosis time of the infrahepatic vena cava.
Split liver transplantation and living liver donor liver transplantation were developed in the clinic to utilize liver organs in a more efficient manner. To better understand the mechanism behind these surgical procedures, a rat partial liver transplantation (PLTx) model was established for relevant surgical studies. Because of the complexity of the rat PLTx model, a protocol with detailed descriptions is required. An article published previously reported a protocol in which ex vivo hepatectomy was used to achieve 50% rat PLTx. In contrast to this protocol, we introduced a re-arterialized PLTx with an in vivo 70% hepatectomy. An updated vessel-oriented hepatectomy was incorporated into the rat PLTx to refine the microsurgical procedure. The portal veins and hepatic arteries of the left lateral lobe and the median lobe were individually dissected and ligated before removal of the liver parenchyma, thereby decreasing the probability of bleeding in the remnant liver stump. Furthermore, an end-to-side vessel anastomosis between the common hepatic artery and the enlarged proper hepatic artery was introduced to re-arterialize the hepatic artery. By using this end-to-side vessel anastomosis technique, the diameter of the anastomosis was enlarged, thereby decreasing the difficulty of hand suture and maintaining a high rate of anastomotic patency. Moreover, the cuff anastomosis of the infrahepatic vena cava was slightly modified. A section of circumferential liver parenchyma around the vena cava of a recipient was preserved during cuff anastomosis to maintain the three-dimensional shape of the vascular lumen. This section of liver parenchyma was removed after completing the anastomosis. With this modification, the step involving placement of stay sutures was omitted, thereby further shortening the cuff anastomosis time. By using this protocol of rat PLTx, a low liver enzyme level, an intact liver lobular architecture and a high survival rate were achieved after microsurgery.
Currently, there is a large discrepancy between the number of donated liver organs and the number of patients waiting for a donated liver. The shortage of liver organs is a global problem. To expand the donor pool, split liver transplantation (LTx) and living donor LTx were developed to use a partial liver as a graft1.
To further investigate the mechanism behind partial liver transplantation (PLTx), relevant animal models have been established2,3,4,5. In rat PLTx, the liver lobes are resected in vivo and ex vivo to mimic the conditions of the living donor LTx and split LTx, respectively, in human. A paper published in the Journal of Visualized Experiments presented a detailed protocol involving a 50% rat PLTx using an ex vivo hepatectomy5. However, a rat PLTx with an in vivo hepatectomy has not yet been reported in the visualized literature.
In addition to the difference between in vivo and ex vivo hepatectomies, the technique of performing a hepatectomy itself also plays an important role in determining the outcome of PLTx. Currently, in many surgical studies using the rat PTLx model, the liver lobes were resected after placing a simple ligation at the pedicle of the liver lobe2,3,6,7,8,9. However, placing a simple ligation before resection is not suitable for all liver lobes, as different liver lobes have different shapes and sizes. A simple ligation at the base of the median lobe carries a high risk of causing a constriction of the vena cava, which might eventually affect the outflow of the partial liver graft10,11. Therefore, an update hepatectomy technique based on knowledge of the rat hepatic anatomy is required in the field of rat PTLx.
In the protocol described in this study, an updated vessel-oriented 70% hepatectomy was incorporated into the procedure of the rat PLTx. The portal veins and hepatic arteries of the left lateral lobe (LLL) and median lobe (ML) were dissected and divided individually before removal of the liver parenchyma. Then, the hepatic veins of the LLL and ML were ligated by piercing sutures. By using individual ligations and multiple piercing sutures rather than placing a simple ligation, the remnant stump of the ML was able to spread over the vena cava. Hence, the constriction of the infrahepatic vena cava caused by a surgical ligation was avoided. Additionally, occlusion of the blood supply of the LLL and ML by individual ligations before removal of the liver parenchyma decreased the rate of bleeding in the remnant liver stump, thereby minimizing the influence of blood loss on the experiments11.
For microsurgeons, it is a significant challenge to reconstruct the proper hepatic artery (PHA) of a liver graft because of the extremely small diameter of this vessel. Although the question of whether re-arterialization in LTx is truly necessary is still under debate12,13,14, numerous microsurgical techniques for reconstructing the hepatic artery have been proposed14. Here, we introduce a novel technique for re-arterialization of the liver graft, which anastomoses the common hepatic artery (CHA) to the enlarged PHA in an end-to-side manner. By using this end-to-side technique, two hepatic arteries are connected with an anastomosis of a larger diameter. The larger the diameter of the anastomosis is, the easier hand suturing is to perform and the greater the improvement in the patency of the anastomosis becomes.
All of the procedures followed the guidelines of rodent surgery approved by the Wenzhou Medical University Animal Policy and Welfare Committee 15.
1. Animals
2. Operative Environment
3. Basic Microsurgical Maneuvers
4. Preparation of the Cuff and Biliary Stent
5. Anesthesia and Fixation of the Rats
6. Donor Operation
7. Back-Table Operation (Graft Preparation)
8. Recipient Operation
9. Postoperative Treatments (Analgesia and Antibiotics)
In total, 31 cases of syngeneic arterialized rat PLTx were completed using this protocol. All of the recipients survived until the end of the observation time. The body weight of the recipients began to recover after postoperative day (POD) 4. The slope of the body weight was close to that of a normal Lewis rat after POD 6 (Figure 8), which indirectly implied the recovery of the recipient. Histologically, a slight proliferation of the bile duct was observed i...
Rat PLTx is a sophisticated microsurgical procedure with a training program that is high in cost and long in duration20. The complexity of the rat PLTx protocol has prevented researchers from using this animal model. Compared with full-size rat LTx, rat PLTx presents the microsurgeon not only with the challenge of a transplantation procedure but also with the challenge of liver resection in a small animal. Therefore, a visualized microsurgical protocol describing the whole procedure in detail is e...
All authors have no conflicting interests to disclose.
This research was supported by National Natural Science Foundation of China (Grant No. 81501382) and Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ13H100003 and LQ16H100002).
Name | Company | Catalog Number | Comments |
Surgical microscope | Möller-Wedel, Germany | 654359 | |
Light source | OSRAM (China) Lighting Co., Ltd | 64627 | |
Isoflurane Vaporizer | MIDMARK Corporation | VIP3000 | |
Isoflurane | Baxter Healthcare Corporation | 40032609 | For Inhalation anesthesia |
Normal Saline | Zhejiang Tianrui Pharmaceutical Co., Ltd. | 716092103 | |
Povidone Iodine Solution | HANGZHOU MINSHENG PHARMACEUTICAL | H33021567 | For disinfection |
Hemostatic forceps | Shanghai Medical Instruments(Group) Ltd | J31020 | |
Surgical scissors | Shanghai Medical Instruments(Group) Ltd | JC2116 | |
Needle-holder | Shanghai Medical Instruments(Group) Ltd | J32030 | |
Dressing Forceps | Shanghai Medical Instruments(Group) Ltd | J42020 | |
Mosquito hemostatic forceps | Shanghai Medical Instruments(Group) Ltd | W40340 | For liver resection; For retracting the stay sutures. |
Micro-scissors | Shanghai Medical Instruments(Group) Ltd | WA1040 | |
Micro needle-holder | Shanghai Medical Instruments(Group) Ltd | WA2060 | |
Curved micro typing forceps | Shanghai Medical Instruments(Group) Ltd | WA3061 | |
straight micro typing forceps | Shanghai Medical Instruments(Group) Ltd | WA3060 | |
Micro hemostatic forceps | Shanghai Medical Instruments(Group) Ltd | WA3020 | |
Bulldog clamp | Shanghai Medical Instruments(Group) Ltd | XEC350 | |
Vessel clamps | Shanghai Medical Instruments(Group) Ltd | W40160 | |
Micro Serrefine-curved | Fine Science Tools, Inc | 18055-05 | |
Dacryosyrinx | Shi Zhuo medical instruments Co., Ltd. | 5# curve | Use as the curved needle for forcing out the air bubbles in the vascular lumen |
Sterilized gauze swabs | Fuqing Health & Integral Medical | 20230R | |
5mL syringe | Zhejiang Yusheng Medical Instrument Co.,Ltd | 811932416 | |
18G needles | Shanghai Kindly Enterprise Development Group Co., Ltd | 01-014 | For fixing the upper abdomen wall |
Intima II 22G intraveous catheter | Becton Dickinson Medical Devices (Shanghai) Co Ltd. | 383207y | For making biliary stent; For infusing perfusate |
7-0 polypropylene sutures | Ningbo Medical Needle Co., Ltd | 151026 | For SHVC anastomsis |
6-0 silk suture | Shanghai Pudong Jinhuan Medical Products Co., Ltd | 2650182 | For ligation |
Culture dish (100mm) | Corning Incorporated | 430165 | used in back table for storage ice. The back table dish was placed on it. |
Culture dish (30 mm) | Corning Incorporated | 3296 | As a vessel for organ preservation |
Angiocath 12G intravenous catheter | Becton Dickinson Medical Devices (Shanghai) Co Ltd. | 382277 | For making a IHVC cuff |
Angiocath 14G intravenous catheter | Becton Dickinson Medical Devices (Shanghai) Co Ltd. | 382269 | For making a PV cuff |
Buprenorphine (hydrochloride) | Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd | H12020275 | For analgesic |
Cefuroxime sodium for injection | Esseti FarmaceuticiS.r.l | H20160013 | As an antibiotics |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaPrzeglądaj więcej artyków
This article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone